KORU Medical
KRMD
KORU Medical (KRMD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $8.00 from $7.00 | Mar 13, 2026 |
| Canaccord Genuity | Maintained | Buy | $6.00 | Mar 13, 2026 |
| Lake Street | Maintained | Buy | $8.00 from $6.00 | Dec 22, 2025 |
| Canaccord Genuity | Maintained | Buy | $6.00 from $5.00 | Dec 17, 2025 |
| Piper Sandler | Maintained | Neutral | $3.50 from $4.50 | May 8, 2025 |
| Piper Sandler | Downgraded | Overweight → Neutral | $4.50 | Feb 14, 2025 |
| Craig-Hallum | Maintained | Buy | $6.00 from $5.00 | Jan 17, 2025 |
| Lake Street | Maintained | Buy | $5.00 from $4.00 | Jan 14, 2025 |
| Piper Sandler | Maintained | Overweight | $3.50 from $3.00 | Nov 14, 2024 |
| Canaccord Genuity | Maintained | Buy | $4.00 from $3.00 | Nov 14, 2024 |
| Craig-Hallum | Maintained | Buy | $5.00 from $4.00 | Nov 14, 2024 |
| Piper Sandler | Maintained | Overweight | $3.00 from $2.50 | Aug 8, 2024 |
| B. Riley Securities | Maintained | Buy | $4.00 | Mar 14, 2024 |
| Canaccord Genuity | Maintained | Buy | $3.00 | Dec 7, 2023 |
| Lake Street | Initiated Coverage | Buy | $4.00 | Sep 7, 2023 |
| B. Riley Securities | Initiated Coverage | Buy | $4.50 | Sep 7, 2023 |
| Piper Sandler | Maintained | Overweight | $3.00 from $4.50 | Aug 3, 2023 |
Frequently asked questions
What is the latest analyst rating on KRMD?
On Mar 13, 2026, B. Riley Securities maintained KORU Medical at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
